Expression of CD44 Variant Proteins in Human Colorectal Cancer Is Related to Tumor Progression

Cancer Research

Volumn 53, Issue 20, 1993, Pages 4754-4756

  Wielenga, Vera J M ^a   Heider, Karl Heinz ^b   Offerhaus, G Johan A ^a   Adolf, Günther R ^c   van den Berg, Frank M ^a   Ponta, Helmut ^b   Herrlich, Peter ^b   Pals, Steven T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c Bender and Co GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; EXON; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN INDUCTION;

ADENOMA; ANTIGENS, CD; ANTIGENS, CD44; BLOTTING, SOUTHERN; COLON; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DNA; DNA, NEOPLASM; EXONS; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; NEOPLASM METASTASIS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; RECEPTORS, LYMPHOCYTE HOMING; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL; VARIATION (GENETICS);

EID: 0027517773     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hart, I. R., Goode, N. T., Wilson, R. E. Molecular aspects of the metastatic cascade. Biochim. Biophys. Acta, 989: 65-84, 1989.
2. Seiter, S., Arch, R., Reber, R., Komitowski, D., Hofmann, M., Ponta, H., Herrlich, P., Matsku, S., and Zoller, M. Prevention of tumor metastasis by anti-variant CD44. J. Exp. Med., 177: 443-455, 1993.
3. Günthert, U., Hofmann, M., Rudy, W., Reber, S. Zöller, M., Hausmann, I., Matzku, M., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65: 13-24, 1991.
4. Koopman, G., Heider, K. H., Horst, E., Adolf, G. R. van den Berg, F., Ponta, H., Herrlich, P., and Pals, S. T. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. Exp. Med., 177: 897-904, 1993.
5. Heider, K. H., Horst, E. Berg van den, F., Hofmann, M., Ponta, H., Herrlich, P., and Pals, S. T. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol., 120: 227-233, 1993.
6. Matsamura, Y., and Tarin, D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340: 1053-1058, 1992.
7. Tanabe, K., Ellis, L. M., and Saya, H. Expresssion of CD44R1 adhesion molecule in colon carcinoma and metastasis. Lancet, 341: 725-26, 1993.
8. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767. 1990.
9. Dukes, C. E. The classification of cancer of the rectum. J. Pathol. Biol., 35: 207-221. 1932.
10. Screaton, G. F., Bell, M. V., Jackson, D., Cornelius, F. B., Gerth, U., and Bell, J., Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternative spliced exons. Proc. Natl. Acad. Sci USA, 89: 12160-12164, 1992.
11. Stamenkovic, I., Amiot, M., Pesando, J. M., and Seed, B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell, 56: 1057-1062, 1989.
12. Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matsku, S., Herrlich, P., and Zöller, M. Participation in normal immune responses of a splice variant of CD44 that encodes a metastasis-inducing domain. Science (Washington DC), 257: 682-685, 1992.
13. Herrlich, P. Zöller, M., Pals, S. T. and Ponta, H. CD44, lymphocytes meet metastases. Immunol. Today, 14: 395-399, 1993.